Global NSAIDs Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type 2021
- Published Date: 2021-03-20
- Report ID: 72748
- Pages: 107
-
Format:
Summary
This study analysis was given on a worldwide scale, for instance, present and historical NSAIDs growth analysis, competitive analysis, and also the growth prospects of the major regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from production, revenue and consumption. A quantitative and qualitative analysis of the main players in related regions is introduced, from the perspective of NSAIDs production, NSAIDs revenue, NSAIDs consumption and NSAIDs price.
According to the current situation, many government announced a plan on reopening the national economy, but many countries are still at the stage of rising.Prudent Markets published a report for global NSAIDs market in this environment.
In terms of revenue, this research report indicated that the global NSAIDs market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of NSAIDs industry comprises of Asia, North America, South America, Middle East and Africa, Europe, with the production and revenue data in each of the sub-segments.
The Roche aims at producing XX NSAIDs in 2020, with XX % production to take place in global market, Amgen accounts for a volume share of XX %.
At the upcoming analysis, this report discusses industrial policy, economic environment, in addition to the COVID-19 impact and cost structures of the industry. And this report encompasses the fundamental dynamics of the market which include drivers, opportunities, and challenges faced by the industry. Additionally, this report showed a keen market study of the main consumers, raw material manufacturers and distributors, etc.
Regional Segmentation (Value; Revenue, USD Million, 2016-2027) of NSAIDs Market byPrudent Markets Include
NorthAmerica
Asia
Europe
Middle East & Africa
South America
Competitive Analysis; Who are the Major Players in NSAIDs Market
Roche
Amgen
B-MS
Merck
Pfizer
Novartis
Eli Lilly and Company
Johnson and Johnson
GSK
Sanofi
Boehringer Ingelheim
Zhejiang Jiuzhou Pharmaceutical
Major Type of NSAIDs Covered inPrudent Markets report:
Ibuprofen
Aspirin
Paracetamol
Diclofenac
Others
Application Segments Covered inPrudent Markets Market
Tablets
Capsules
Suspension
Topical Preparations
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global NSAIDs Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Ibuprofen -Product Introduction and Major Manufacturers
1.1.2 Aspirin -Product Introduction and Major Manufacturers
1.1.3 Paracetamol -Product Introduction and Major Manufacturers
1.1.4 Diclofenac -Product Introduction and Major Manufacturers
1.1.5 Others -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market
2.1 Regional Market Share in Terms of Production (2020-2027)
2.2 Regional Market Share in Terms of Revenue (2020-2027)
2.3 Regional Market Share in Terms of Consumption (2020-2027)
3 Global NSAIDs Market Assessment by Type
3.1 Global NSAIDs Production by Type (2016-2027)
3.2 Global NSAIDs Revenue by Type (2016-2027)
3.3 North America NSAIDs Production and Revenue by Type (2016-2027)
3.4 Asia NSAIDs Production and Revenue by Type (2016-2027)
3.5 Europe NSAIDs Production and Revenue by Type (2016-2027)
3.6 Middle East & Africa NSAIDs Production and Revenue by Type (2016-2027)
3.7 South America NSAIDs Production and Revenue by Type (2016-2027)
4 Global NSAIDs Market Assessment by Application
4.1 Historical & Forecast Global NSAIDs Consumption, Different Application Field (2016-2027)
4.2 Historical & Forecast North America NSAIDs Consumption, Different Application Field (2016-2027)
4.3 Historical & Forecast Asia NSAIDs Consumption, Different Application Field (2016-2027)
4.4 Historical & Forecast Europe NSAIDs Consumption, Different Application Field (2016-2027)
4.5 Historical & Forecast Middle East & Africa NSAIDs Consumption, Different Application Field (2016-2027)
4.6 Historical & Forecast South America NSAIDs Consumption, Different Application Field (2016-2027)
5 North America
5.1 US NSAIDs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
5.2 Canada NSAIDs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
5.3 Mexico NSAIDs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
6 Asia
6.1 China NSAIDs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
6.2 Japan NSAIDs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
6.3 India NSAIDs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
6.4 Korea NSAIDs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
6.5 Southeat Asia NSAIDs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
7 Europe
7.1 Germany NSAIDs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
7.2 UK NSAIDs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
7.3 France NSAIDs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
7.4 Russia NSAIDs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
7.5 Italy NSAIDs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
8 Middle East and Africa
8.1 Saudi NSAIDs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
8.2 UAE NSAIDs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
8.3 Egypt NSAIDs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
8.4 Nigeria NSAIDs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
8.5 South Africa NSAIDs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
9 South America
9.1 Brazil NSAIDs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
9.2 Argentina NSAIDs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
9.3 Colombia NSAIDs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
10 Global NSAIDs Average Price Trend
10.1 Market Price for Each Type of NSAIDs in North America (2016-2027)
10.2 Market Price for Each Type of NSAIDs in Asia (2016-2027)
10.3 Market Price for Each Type of NSAIDs in Europe (2016-2027)
10.4 Market Price for Each Type of NSAIDs in Middle East & Africa (2016-2027)
10.5 Market Price for Each Type of NSAIDs in South America (2016-2027)
11 Value Chain (Impact of COVID-19)
11.1 NSAIDs Value Chain Analysis
11.1.1 Upstream
11.1.2 Downstream
11.2 COVID-19 Impact on NSAIDs Industry
11.2.1 Industrial Policy Issued Under the Epidemic Situation
11.3 Cost-Under the Epidemic Situation
11.3.1 Cost of Raw Material
11.4 Channel Analysis
11.4.1 Distribution Channel-Under the Epidemic Situation
11.4.2 Distributors
12 NSAIDs Competitive Analysis
12.1 Roche
12.1.1 Roche Company Profiles
12.1.2 Roche Product Introduction
12.1.3 Roche NSAIDs Production, Revenue (2015-2020)
12.1.4 SWOT Analysis
12.2 Amgen
12.2.1 Amgen Company Profiles
12.2.2 Amgen Product Introduction
12.2.3 Amgen NSAIDs Production, Revenue (2015-2020)
12.2.4 SWOT Analysis
12.3 B-MS
12.3.1 B-MS Company Profiles
12.3.2 B-MS Product Introduction
12.3.3 B-MS NSAIDs Production, Revenue (2015-2020)
12.3.4 SWOT Analysis
12.4 Merck
12.4.1 Merck Company Profiles
12.4.2 Merck Product Introduction
12.4.3 Merck NSAIDs Production, Revenue (2015-2020)
12.4.4 SWOT Analysis
12.5 GSK
12.5.1 Pfizer Company Profiles
12.5.2 Pfizer Product Introduction
12.5.3 Pfizer NSAIDs Production, Revenue (2015-2020)
12.5.4 SWOT Analysis
12.6 Novartis
12.6.1 Novartis Company Profiles
12.6.2 Novartis Product Introduction
12.6.3 Novartis NSAIDs Production, Revenue (2015-2020)
12.6.4 SWOT Analysis
12.7 Eli Lilly and Company
12.7.1 Eli Lilly and Company Company Profiles
12.7.2 Eli Lilly and Company Product Introduction
12.7.3 Eli Lilly and Company NSAIDs Production, Revenue (2015-2020)
12.7.4 SWOT Analysis
12.8 Johnson and Johnson
12.8.1 Johnson and Johnson Company Profiles
12.8.2 Johnson and Johnson Product Introduction
12.8.3 Johnson and Johnson NSAIDs Production, Revenue (2015-2020)
12.8.4 SWOT Analysis
12.9 GSK
12.9.1 GSK Company Profiles
12.9.2 GSK Product Introduction
12.9.3 GSK NSAIDs Production, Revenue (2015-2020)
12.9.4 SWOT Analysis
12.10 Sanofi
12.10.1 Sanofi Company Profiles
12.10.2 Sanofi Product Introduction
12.10.3 Sanofi NSAIDs Production, Revenue (2015-2020)
12.10.4 SWOT Analysis
12.11 Boehringer Ingelheim
12.12 Zhejiang Jiuzhou Pharmaceutical
13 Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
